Bradsaude (BSP:SAUD3) Equivalent Admissions #


BSP:SAUD3 Bradsaude SA BSP:SAUD3
93 GF Score
Price R$14.62
GF Value R$13.50
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Bradsaude Equivalent Admissions #?

Equivalent Admissions # only apply to companies which has operating data in Healthcare industry.

BSP:SAUD3
93GF Score
Bradsaude SA BSP:SAUD3
Equivalent Admissions # is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bradsaude (BSP:SAUD3) Overvalued in 2026?

Based on GuruFocus' analysis, Bradsaude stock appears to be overvalued. The current stock price of R$14.62 is trading 8.3% above its estimated GF Value™ of R$13.50. GuruFocus considers Bradsaude to be Fairly Valued.

Key valuation signals for BSP:SAUD3:

  • Equivalent Admissions #:
  • GF Value™: R$13.50 vs. price of R$14.62 (8.3% above fair value)
  • GF Score™: 93/100 with 6 warning signs

No single metric tells the full story. See the BSP:SAUD3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bradsaude Business Description

Address Alameda Araguaia, 2104, 21 andar, Alphaville, Barueri, SP, BRA, 06460-040
Bradsaude SA operates a healthcare ecosystem in Brazil formed through the consolidation of companies across different healthcare segments. Its operations include health and dental insurance, hospitals, primary care clinics, healthcare technology, diagnostics, and oncology services. The company serves more than 13 million beneficiaries and operates a healthcare network that includes approximately 4,000 hospital beds across the country.
93GF Score

Get the complete analysis for BSP:SAUD3

Equivalent Admissions # is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$14.62
Price
R$13.50
GF Value